---
title: 'ROS1 fusions in resected stage I-III adenocarcinoma: Results from the European
  Thoracic Oncology Platform Lungscape project'
date: '2024-07-13'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39002492/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240714181442&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: The prevalence of ROS1 fusion in an LUAD stage I-III European
  cohort was relatively low. ROS1 IHC using SP384 clone is useful for exclusion of
  ROS1 gene fusion negative ...'
disable_comments: true
---
CONCLUSIONS: The prevalence of ROS1 fusion in an LUAD stage I-III European cohort was relatively low. ROS1 IHC using SP384 clone is useful for exclusion of ROS1 gene fusion negative ...